share_log

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(4.4%),Daniel B. Asher(4.4%), etc.

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals

Aslan Pharmaceuticals | SC 13G:超过5%持股股东披露文件
美股sec公告 ·  03/21 16:47
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息